RAPIDITY OF SYMPTOM IMPROVEMENTS DURING FILGOTINIB INDUCTION THERAPY IN PATIENTS WITH ULCERATIVE COLITIS: POST HOC ANALYSIS OF THE PHASE 2B/3 SELECTION STUDY

Silvio Danese  1     Toshifumi Hibi  2     Jeremy Hsieh  3     Chohee Yun  3     Jie Zhang  3     Sally Zhao  3     Edward V Loftus Jr  4     Gerhard Rogler  5     Timothy Ritter  6     Jason Dinoso  3    
1 Humanitas Clinical and Research Center, IRCCS and Humanitas University, Milan, Italy
2 Kitasato Institute Hospital, Kitasato University, Tokyo, Japan
3 Gilead Sciences, Inc., Foster City, CA, United States
4 Mayo Clinic College of Medicine, Rochester, MN, United States
5 University Hospital of Zurich, University of Zurich, Zurich, Switzerland
6 GI Alliance, Southlake, TX, United States

Topic
IBD

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing